13F filer · CIK 2111609
Ishara Investments LP
LOS ANGELES, CA · filing since Q4 2025 · last filing Aug 14, 2026
Reported value
$136.1M
+$30.5M vs prior
Positions
41
New / sold out
16 / 12
Added / reduced
13 / 8
Turnover
47.0%
buys $67.3M · sells $56.8M
Top-10 weight
51.0%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | ACADIA PHARMACEUTICALS INC | +287,000 | +233.3% | +$7.3M |
| New | AGIOS PHARMACEUTICALS INC | +164,000 | – | +$6.1M |
| New | INSMED INC | +51,250 | – | +$5.5M |
| New | CRINETICS PHARMACEUTICALS IN | +143,500 | – | +$5.4M |
| New | TONIX PHARMACEUTICALS HLDG C | +338,250 | – | +$4.3M |
| New | BRIDGEBIO PHARMA INC | +57,400 | – | +$4.3M |
| Added | ANNEXON INC | +645,750 | +370.6% | +$3.7M |
| Added | BIOMARIN PHARMACEUTICAL INC | +61,500 | +75.0% | +$3.5M |
| New | KURA ONCOLOGY INC | +276,750 | – | +$3.0M |
| New | CYTOKINETICS INC | +32,800 | – | +$2.8M |
19 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | PRAXIS PRECISION MEDICINES IPUT | -20,500 | -100.0% | $-6.6M |
| Reduced | AXSOME THERAPEUTICS INC. | -24,600 | -60.0% | $-6.0M |
| Sold out | KALVISTA PHARMACEUTICALS INC | -276,750 | -100.0% | $-5.6M |
| Sold out | AMICUS THERAPEUTIC | -369,000 | -100.0% | $-5.3M |
| Sold out | VERASTEM INC | -820,000 | -100.0% | $-4.3M |
| Reduced | SILENCE THERAPEUTICS PLC | -85,150 | -60.6% | $-3.7M |
| Sold out | ARROWHEAD PHARMACEUTICALS IN | -55,350 | -100.0% | $-3.5M |
| Sold out | MOONLAKE IMMUNOTHERAPEUTICS | -174,250 | -100.0% | $-3.2M |
| Reduced | VERA THERAPEUTICS INC | -71,750 | -87.5% | $-3.1M |
| Sold out | ARDELYX INC | -451,000 | -100.0% | $-2.7M |
10 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ACADIA PHARMACEUTICALS INCCOM | 410,000 | $10.4M | 7.62% |
| 2 | XERIS BIOPHARMA HOLDINGS INCCOM | 1,230,000 | $9.7M | 7.16% |
| 3 | BIOMARIN PHARMACEUTICAL INCCOM | 143,500 | $8.2M | 6.03% |
| 4 | PRAXIS PRECISION MEDICINES ICOM NEW | 22,550 | $7.5M | 5.55% |
| 5 | ULTRAGENYX PHARMACEUTICAL INCOM | 205,000 | $6.8M | 5.03% |
| 6 | AGIOS PHARMACEUTICALS INCCOM | 164,000 | $6.1M | 4.47% |
| 7 | INSMED INCCOM PAR $.01 | 51,250 | $5.5M | 4.01% |
| 8 | CRINETICS PHARMACEUTICALS INCOM | 143,500 | $5.4M | 3.95% |
| 9 | ZENTALIS PHARMACEUTICALS INCCOM | 1,025,000 | $5.0M | 3.65% |
| 10 | VAXCYTE INCCOM | 82,000 | $4.8M | 3.50% |
31 more rows. Subscribe for $29/month to see every row, download the data and use the API.